Product overviewResearch information
CJC-1295 with DAC is a synthetic peptide analogue developed from growth hormone-releasing hormone and incorporates a Drug Affinity Complex designed to facilitate albumin binding in experimental models.
It is investigated in research involving GHRH receptor signalling, growth hormone-related pathways, peptide pharmacokinetics and neuroendocrine mechanisms.
Product information
CompoundCJC-1295 with DAC
FormatLyophilised powder
ModificationDrug Affinity Complex (DAC)
Research areaGHRH receptor signalling, peptide pharmacokinetics & endocrine pathways
Available options2mg / 5mg